Home > News > Show Me A Sign
September 15th, 2005
Show Me A Sign
Joe Alper: Initial clinical trials with some of these apoptosis detectors have shown promise, and now investigators are bringing the power of nanotechnology to bear on this effort in order to create powerful systems that would ultimately be capable of both delivering an anti-tumor drug and monitoring, in real time, if it is triggering cell death. The development of a nanotechnology-enabled apoptosis detector is one of the strategic areas of emphasis of the NCI Alliance for Nanotechnology in Cancer.
Though this work is still in its early stages, its potential is a harbinger of things to come. "Having a real-time apoptosis detector would represent a significant advance in cancer therapy, one that would let us alter treatment to reflect how each patient responds to a given set of drugs soon after being given those drugs," remarked James Olson, M.D.
European roadmap for graphene science and technology published February 25th, 2015
Quantum research past, present and future for discussion at AAAS February 16th, 2015
World’s first compact rotary 3D printer-cum-scanner unveiled at AAAS by NTU Singapore start-up: With production funded by crowdsourcing, the first unit will be delivered to the United States in March February 16th, 2015
Nanotechnology Electric Vehicle (EV) Market Analysis Report 2015: According to Radiant Insights, Inc February 13th, 2015
Democratizing synthetic biology: New method makes research cheaper, faster, and more accessible March 3rd, 2015
Pens filled with high-tech inks for do-it-yourself sensors March 3rd, 2015
New nanodevice defeats drug resistance: Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs March 2nd, 2015
New Hopes for Treatment of Intestine Cancer by Edible Nanodrug March 2nd, 2015